The EurAsian Economic Union is a regional economic integration that aims to promote economic cooperation, stability, and expansion among its member states. In total, the pharmaceutical market of the EAEU exceeds 30 billion US dollars. Kazakhstan, Russia, Belarus, Kyrgyzstan, and Armenia have common registration rules for medicines MD, and dietary supplements regulated by the EAEU Commission
The fast-growing pharmaceutical markets of the five Central Asian countries (Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan and Turkmenistan) with a total population of 80 million people are an attractive area for expanding your business.
The stable development of the markets of the Caucasian countries continues, despite the geopolitical events in neighboring countries. The pharmaceutical market of Azerbaijan, Armenia, and Georgia, which is easy to access, exceeds $1 billion and continues to grow.
The region typically includes around 21 countries and accounts for approximately 6% of the world's population. According to OPEC data, the MENA region holds more than half of the world's oil reserves and two-fifths of the world's natural gas reserves. The pharmaceutical market in MENA is growing. Many countries in the region are focused on developing their own pharmaceutical industry. The largest companies in the region supply high-quality and inexpensive products to Europe and America.